Literature DB >> 25700839

Molecular mechanisms underlying PINK1 and Parkin catalyzed ubiquitylation of substrates on damaged mitochondria.

Fumika Koyano1, Noriyuki Matsuda2.   

Abstract

PINK1 and Parkin are gene products that cause genetic recessive Parkinsonism. PINK1 is a protein kinase and Parkin is a ubiquitin ligase (E3) that links ubiquitin to a substrate. Importantly, under steady state conditions, the enzymatic activity of Parkin is completely suppressed, but is activated when mitochondria become abnormal. In 2013 and 2014, biochemical and structure-function analyses revealed a number of critical mechanistic insights. First, Parkin is a self-inhibitory E3 that suppresses its E3 activity via intramolecular interactions. Second, in response to a decrease in mitochondrial membrane potential, PINK1 phosphorylates Ser65 in both the Parkin ubiquitin-like domain and ubiquitin itself. These phosphorylation events cooperate to relieve the Parkin autoinhibition. Third, activated Parkin forms a ubiquitin-thioester bond at Cys431 to produce a reaction intermediate that catalyzes ubiquitylation of substrates on damaged mitochondria. While the molecular mechanism regulating Parkin enzymatic activity has largely eluded clarification, a complete picture is now emerging.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Activation; E3; PINK1; Parkin; Ubiquitin

Mesh:

Substances:

Year:  2015        PMID: 25700839     DOI: 10.1016/j.bbamcr.2015.02.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

Review 1.  Parkin and PINK1 functions in oxidative stress and neurodegeneration.

Authors:  Sandeep K Barodia; Rose B Creed; Matthew S Goldberg
Journal:  Brain Res Bull       Date:  2016-12-23       Impact factor: 4.077

2.  Interaction between RING1 (R1) and the Ubiquitin-like (UBL) Domains Is Critical for the Regulation of Parkin Activity.

Authors:  Su Jin Ham; Soo Young Lee; Saera Song; Ju-Ryung Chung; Sekyu Choi; Jongkyeong Chung
Journal:  J Biol Chem       Date:  2015-12-02       Impact factor: 5.157

Review 3.  Phospho-ubiquitin: upending the PINK-Parkin-ubiquitin cascade.

Authors:  Noriyuki Matsuda
Journal:  J Biochem       Date:  2016-02-02       Impact factor: 3.387

4.  Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1.

Authors:  Yu-Chiang Lai; Chandana Kondapalli; Ronny Lehneck; James B Procter; Brian D Dill; Helen I Woodroof; Robert Gourlay; Mark Peggie; Thomas J Macartney; Olga Corti; Jean-Christophe Corvol; David G Campbell; Aymelt Itzen; Matthias Trost; Miratul Mk Muqit
Journal:  EMBO J       Date:  2015-10-15       Impact factor: 11.598

5.  Mechanism of phospho-ubiquitin-induced PARKIN activation.

Authors:  Tobias Wauer; Michal Simicek; Alexander Schubert; David Komander
Journal:  Nature       Date:  2015-07-10       Impact factor: 49.962

Review 6.  The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis.

Authors:  Heather D E Booth; Warren D Hirst; Richard Wade-Martins
Journal:  Trends Neurosci       Date:  2017-05-17       Impact factor: 13.837

Review 7.  Generation and Release of Mitochondrial-Derived Vesicles in Health, Aging and Disease.

Authors:  Anna Picca; Flora Guerra; Riccardo Calvani; Hélio José Coelho-Junior; Maurizio Bossola; Francesco Landi; Roberto Bernabei; Cecilia Bucci; Emanuele Marzetti
Journal:  J Clin Med       Date:  2020-05-12       Impact factor: 4.241

Review 8.  Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin?

Authors:  Jaime M Ross; Lars Olson; Giuseppe Coppotelli
Journal:  Int J Mol Sci       Date:  2015-08-17       Impact factor: 5.923

Review 9.  Multiple Roles of the Small GTPase Rab7.

Authors:  Flora Guerra; Cecilia Bucci
Journal:  Cells       Date:  2016-08-18       Impact factor: 6.600

10.  Parkinson's disease-related DJ-1 functions in thiol quality control against aldehyde attack in vitro.

Authors:  Noriyuki Matsuda; Mayumi Kimura; Bruno Barros Queliconi; Waka Kojima; Masaki Mishima; Kenji Takagi; Fumika Koyano; Koji Yamano; Tsunehiro Mizushima; Yutaka Ito; Keiji Tanaka
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.